2014
DOI: 10.4238/2014.january.10.6
|View full text |Cite
|
Sign up to set email alerts
|

Biochip analysis of prostate cancer

Abstract: ABSTRACT. Microarray expression analysis was used to forecast the roles of differentially co-expressed genes (DCG) and DCG and links in the pathogenesis of prostate cancer. In addition, we demonstrate that the relationship between transcriptional factors (TFs) and their targets can be considered a key factor in determining the difference between primary and metastatic prostate cancer. Regulatory impact factors were adopted to calculate the impact of TF. We identified 5 TFs and 29 target genes important in the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 39 publications
0
1
0
Order By: Relevance
“…There is a screening test that looks for the level of the prostate-specific antigen in serum. But this test has only an 85% predictive value and men who many have high levels may not progress to having cancer [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…There is a screening test that looks for the level of the prostate-specific antigen in serum. But this test has only an 85% predictive value and men who many have high levels may not progress to having cancer [ 2 ].…”
Section: Introductionmentioning
confidence: 99%